Achieve Life Sciences (ACHV) FCF Margin (2010 - 2016)
Achieve Life Sciences' (ACHV) quarterly FCF Margin came in at 309.08% in Q1 2016, up 17483.0% YoY from N/an in Q2 2015, and down 905.89% on a QoQ basis from 30.73% in Q4 2015.
Powered by 
Analysis
Achieve Life Sciences (ACHV) FCF Margin (2010 - 2016) Analysis & Trends
Achieve Life Sciences (ACHV) has 7 years of FCF Margin data on file, last reported at 309.08% in Q1 2016.
- Quarterly FCF Margin rose 17483.0% year-over-year to 309.08% in Q1 2016, while the trailing twelve-month figure through Mar 2016 was 15.24% (up 11806.0% YoY) and the FY2015 annual result came in at 3.13%, up 6100.0% from the prior year.
- FCF Margin declined to 309.08% in Q1 2016, from 30.73% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 412.42% in Q2 2015 to a low of 563.11% in Q2 2012.
- A 5-year average of 164.83% and a median of 120.2% in 2014 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 47272 bps in 2015, down 46943 bps in 2015.
- Tracing ACHV's FCF Margin over 5 years: stood at 98.92% in 2012, then climbed by 11 bps to 87.83% in 2013, then tumbled by 40 bps to 122.87% in 2014, then jumped by 75 bps to 30.73% in 2015, then tumbled by 906 bps to 309.08% in 2016.
- The last three FCF Margin figures came in at 309.08% (Q1 2016), 30.73% (Q4 2015), and 128.66% (Q3 2015), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | -309.08% |
| Dec 31, 2015 | -33.27% |
| Sep 30, 2015 | -128.66% |
| Jun 30, 2015 | 412.42% |
| Mar 31, 2015 | -483.92% |
| Dec 31, 2014 | -122.87% |
| Sep 30, 2014 | -120.20% |
| Jun 30, 2014 | -60.30% |
| Mar 31, 2014 | -14.48% |
| Dec 31, 2013 | -87.83% |
| Sep 30, 2013 | -103.83% |
| Jun 30, 2013 | -119.59% |
| Mar 31, 2013 | -212.79% |
| Dec 31, 2012 | -98.92% |
| Sep 30, 2012 | -197.26% |
| Jun 30, 2012 | -563.11% |
| Mar 31, 2012 | -561.02% |
| Dec 31, 2011 | -359.47% |
| Sep 30, 2011 | -528.11% |
| Jun 30, 2011 | -298.04% |